A REVIEW OF ADVANCED NANOTECHNOLOGIES AND DRUG DELIVERY SYSTEMS OF SALINOMYCIN AND THEIR ROLE IN TRIPLE-NEGATIVE BREAST CANCER

Authors

  • GOKUL RAJ R. Department of Pharmaceutics, JSS College of Pharmacy, JSSAHER, SS Nagara, Mysuru-570015, Karnataka, India
  • PREETHI S. Department of Pharmaceutics, JSS College of Pharmacy, JSSAHER, SS Nagara, Mysuru-570015, Karnataka, India
  • AMIT B. PATIL Department of Pharmaceutics, JSS College of Pharmacy, JSSAHER, SS Nagara, Mysuru-570015, Karnataka, India
  • VIKAS JAIN Department of Pharmaceutics, JSS College of Pharmacy, JSSAHER, SS Nagara, Mysuru-570015, Karnataka, India
  • RAMKISHAN AJMEER Department of Pharmaceutics, JSS College of Pharmacy, JSSAHER, SS Nagara, Mysuru-570015, Karnataka, India

DOI:

https://doi.org/10.22159/ijap.2022v14i4.44237

Keywords:

Salinomycin, Breast cancer, Nanotechnology, Drug delivery system

Abstract

Cancer cells spread to other tissues and organs when they divide incorrectly. Breast cancer (BC) is the main cause of cancer-related mortality globally. Some recent studies on cancer stem cells (CSCs), drug resistance, tumor recurrence and metastasis, and the significance of CD44+ in targeted treatment for breast cancer are covered. Breast cancer stem cells(BCSCs) and bulk BC cells must be eliminated for the disease to be eliminated. Researchers have shown that Streptomyces Albus-derived monocarboxylic polyether antibiotic salinomycin kills human cancer stem cells (CSCs) and prevents the spread and growth of breast cancer cells. Several drug and apoptosis resistance mechanisms may also trigger apoptosis in breast cancer cells when salinomycin is used in combination with the treatment. Apoptosis-resistant cancer cells and cancer stem cells are both susceptible to the anticancer drug salinomycin. Salinomycin may be able to inhibit CSCs, as well as the source and structure modification of salinomycin analog exhibit potent anticancer activity, the effect of salinomycin on chemotherapeutic-resistant CSCs, and the various mechanisms by which salinomycin inhibits cancer stem cells in this study. Method and delivery technique for salinomycin Nano formulation in triple-negative breast cancer and also contains pharmacokinetics and toxicity of salinomycin. Salinomycin-based drug delivery system is the subject of the patent information. Tumor genesis, development, and invasion are all aided by salinomycin. It's possible to boost the effectiveness of cancer therapy by focusing on cancer stem cells (CSCs).

Downloads

Download data is not yet available.

References

Miller Kd, Sauer Ag, Fedewa Sa. Colorectal Cancer Statistics, 2020. 2020;70(3):145–64.

Loomis D, Huang W, Chen G. The International Agency For Research On Cancer ( IARC ) Evaluation Of The Carcinogenicity Of Outdoor Air Pollution : Focus On China. 2013;189–96.

S. P, Kumar H, Rawal Vb, Ajmeer R, Jain V. Overview Of Mitoxantrone - A Potential Candidate For Treatment Of Breast Cancer. Int J Appl Pharm. 2021;14(2).

Denny Dc, Ss Y, R V, Fardan M, Iype Ds, K Am. Cardiovascular Risk Associated With Androgen Deprivation Therapy In Advanced Prostate Cancer. Asian J Pharm Clin Res. 2021 Aug 7;6–9.

Momenimovahed Z, Salehiniya H. Epidemiological Characteristics Of And Risk Factors For Breast Cancer In The World. Breast cancer (Dove Med Press. 2019 Apr 10;11:151–64.

Mannan AU, Singh J, Lakshmikeshava R, Thota N, Singh S, Sowmya TS, Mishra A, Sinha A, Deshwal S, Soni MR, Chandrasekar A, Ramesh B, Ramamurthy B, Padhi S, Manek P, Ramalingam R, Kapoor S, Ghosh M, Sankaran S, Ghosh A, Veeramachaneni V, Ramamoorthy P, Hariharan R, Subramanian K. Detection Of High Frequency Of Mutations In A Breast And / Or Ovarian Cancer Cohort : implications of embracing a multi-gene panel in molecular diagnosis in India. 2016;(October 2015):515–22.

Kumar A. Comprehensive Review On Etiopathogenesis, Treatment And Emerging Therapies Of Breast Cancer. Asian J Pharm Clin Res. 2021;14(8):20–33.

Ayuni Lubakisar Yq, Fauziah F, Bellatasie R. Immunomodulator Activity Of Mangiferin From Mango (Mangifera Indica L.) In Cancer: A Systematic Review. Int J Pharm Pharm Sci. 2021 Oct 1;7–11.

Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK. Various Types And Management Of Breast Cancer: An Overview. J Adv Pharm Technol Res. 2010 Apr;1(2):109–26.

Fisher B. From Halsted To Prevention And Beyond: Advances In The Management Of Breast Cancer During The Twentieth Century. Eur J Cancer. 1999;35(14):1963–73.

Wielsøe M, Gudmundsdottir S, Bonefeld-Jørgensen EC. Reproductive History And Dietary Habits And Breast Cancer Risk In Greenlandic Inuit: A Case Control Study. Public Health. 2016;137:50–8.

Hanf V, Hanf D. Reproduction And Breast Cancer Risk. Breast Care. 2014;9(6):398–405.

Wang X, Li L, Gao J, Liu J, Guo M, Liu L, Wang W, Wang J, Xing Z, Yu Z, Wang X. The Association Between Body Size And Breast Cancer In Han Women In Northern And Eastern China. Oncologist. 2016 Nov;21(11):1362–8.

Shield Kd, Soerjomataram I, Rehm J. Alcohol Use And Breast Cancer: A Critical Review. Alcohol Clin Exp Res. 2016 Jun;40(6):1166–81

Pastor-Barriuso R, Fernández Mf, Castaño-Vinyals G, Whelan D, Pérez-Gómez B, Llorca J, Villanueva Cm, Guevara M, Molina-Molina J-M, Artacho-Cordón F, Barriuso-Lapresa L, Tusquets I, Dierssen-Sotos T, Aragonés N, Olea N, Kogevinas M, Pollán M. Total Effective Xenoestrogen Burden In Serum Samples And Risk For Breast Cancer In A Population-Based Multicase-Control Study In Spain. Environ Health Perspect. 2016 Oct;124(10):1575–82.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN. Overview Of Resistance To Systemic Therapy In Patients With Breast Cancer. Adv Exp Med Biol. 2007;608:1–22.

Bhutadiya Vl, Mistry Kn. A Review On Bioactive Phytochemicals And It’s Mechanism On Cancer Treatment And Prevention By Targeting Multiple Cellular Signaling Pathways. Int J Pharm Pharm Sci. 2021 Dec 1;15–9.

Hubalek M, Czech T, Müller H. Biological Subtypes Of Triple-Negative Breast Cancer. Breast Care. 2017;12(1):8–14.

Yin L, Duan J-J, Bian X-W, Yu S. Triple-Negative Breast Cancer Molecular Subtyping And Treatment Progress. Breast Cancer Res. 2020;22(1):61.

Nair M, Singh Sandhu S, K Sharma A. Prognostic And Predictive Biomarkers In Cancer. Curr Cancer Drug Targets. 2014;14(5):477–504.

Weaver BA. How Taxol/Paclitaxel Kills Cancer Cells. Mol Biol Cell. 2014 Sep 15;25(18):2677–81.

Naemi A-O, Dey H, Kiran N, Sandvik ST, Slettemeås JS, Nesse LL, Simm R. Narab Is An ABC-Type Transporter That Confers Resistance To The Polyether Ionophores Narasin, Salinomycin, And Maduramicin, But Not Monensin. Front Microbiol. 2020 Feb 4;11.

Rutkowski J, Brzezinski B. Structures And Properties Of Naturally Occurring Polyether Antibiotics. Biomed Res Int. 2013/03/17. 2013;2013:162513.

Tan C, Tan H, Zhang J. [Enhancement Of Salinomycin Production And Its Activity Optimization - A Review]. Wei Sheng Wu Xue Bao. 2016 Sep;56(9):1371–84.

Lu C, Zhang X, Jiang M, Bai L. Enhanced Salinomycin Production By Adjusting The Supply Of Polyketide Extender Units In Streptomyces Albus. Metab Eng. 2016 May;35:129–37.

Zhen X, Choi HS, Kim J-H, Kim S-L, Liu R, Yun B-S, Lee D-S. Machilin D, A Lignin Derived From Saururus Chinensis, Suppresses Breast Cancer Stem Cells And Inhibits NF-Κb Signaling. Biomolecules. 2020;10(2).

Kumar S, Kaur R, Rajput R, Singh M. Bio Pharmaceutics Classification System (BCS) Class IV Drug Nanoparticles: Quantum Leap To Improve Their Therapeutic Index. Adv Pharm Bull. 2018/11/29. 2018 Nov;8(4):617–25.

Zhang Y, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. The Eradication Of Breast Cancer And Cancer Stem Cells Using Octreotide Modified Paclitaxel Active Targeting Micelles And Salinomycin Passive Targeting Micelles. Biomaterials. 2012 Jan;33(2):679–91.

Wen H, Jung H, Li X. Drug Delivery Approaches In Addressing Clinical Pharmacology-Related Issues: Opportunities And Challenges. AAPS J. 2015 Nov;17(6):1327–40.

Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer Nanomedicine: Progress, Challenges And Opportunities. Nat Rev Cancer. 2017;17(1):20–37.

Furtula V, Stephenson GL, Olaveson KM, Chambers PA. Effects Of The Veterinary Pharmaceutical Salinomycin And Its Formulation On The Plant Brassica Rapa. Arch Environ Contam Toxicol. 2012;63(4):513–22.

Momekova D, Momekov G, Ivanova J, Pantcheva I, Drakalska E, Stoyanov N, Guenova M, Michova A, Balashev K, Arpadjan S. Sterically Stabilized Liposomes As A Platform For Salinomycin Metal Coordination Compounds: Physicochemical Characterization And In Vitro Evaluation. J Drug Deliv Sci Technol. 2013;23(3):215–23.

Li H, Luo W, Wang Q, Yu X. Direct Fermentation Of Gelatinized Cassava Starch To Acetone, Butanol, And Ethanol Using Clostridium Acetobutylicum Mutant Obtained By Atmospheric And Room Temperature Plasma. Appl Biochem Biotechnol. 2014 Apr 12;172(7):3330–41.

Michel AR. Synthesis And Characterization Of Novel Silicate Prodrugs And Block Copolymers For Use Into Nanoparticle Drug Delivery. ProQuest Diss Theses. 2015;(October):405.

Schlüsener MP, Bester K. Persistence Of Antibiotics Such As Macrolides, Tiamulin And Salinomycin In Soil. Environ Pollut. 2006;143(3):565–71.

Antoszczak M. A Comprehensive Review Of Salinomycin Derivatives As Potent Anticancer And Anti-Cscs Agents. Eur J Med Chem. 2019;166:48–64.

Pasenkiewicz-Gierula M, Baczynski K, Markiewicz M, Murzyn K. Computer Modelling Studies Of The Bilayer/Water Interface. Biochim Biophys Acta - Biomembr.2016;1858(10):2305–21.

Ross MF, Kelso GF, Blaikie FH, James AM, Cochemé HM, Filipovska A, Da Ros T, Hurd TR, Smith RAJ, Murphy MP. Lipophilic Triphenylphosphonium Cations As Tools In Mitochondrial Bioenergetics And Free Radical Biology. Biochem. 2005 Feb;70(2):222–30.

Frankel DA, O’Brien DF. Supramolecular Assemblies Of Diacetylenic Aldonamides. J Am Chem Soc. 1994 Nov 1;116(22):10057–69.

Watson H. Biological Membranes. Essays Biochem. 2015;59:43–69.

Hu C-MJ, Aryal S, Zhang L. Nanoparticle-Assisted Combination Therapies For Effective Cancer Treatment. Ther Deliv. 2010;1(2):323–34.

Antoszczak M, Popiel K, Stefańska J, Wietrzyk J, Maj E, Janczak J, Michalska G, Brzezinski B, Huczyński A. Synthesis, Cytotoxicity And Antibacterial Activity Of New Esters Of Polyether Antibiotic–Salinomycin. Eur J Med Chem. 2014;76:435–44.

Huczyński A, Janczak J, Stefańska J, Antoszczak M, Brzezinski B. Synthesis And Antimicrobial Activity Of Amide Derivatives Of Polyether Antibiotic—Salinomycin. Bioorg Med Chem Lett. 2012;22(14):4697–702.

Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The Different Mechanisms Of Cancer Drug Resistance: A Brief Review. Adv Pharm Bull. 2017/09/25. 2017 Sep;7(3):339–48.

Zhang W, Wu J, Li B, Lian X, Xia J, Zhou Q, Wu S. Design And Synthesis Of Conformationally Constrained Salinomycin Derivatives. Eur J Med Chem. 2017;138:353–6.

Czerwonka D, Mielczarek-Puta M, Antoszczak M, Cioch A, Struga M, Huczyński A. Evaluation Of The Anticancer Activity Of Singly And Doubly Modified Analogues Of C20-Epi-Salinomycin. Eur J Pharmacol. 2021;908:174347.

Vinogradov S, Wei X. Cancer Stem Cells And Drug Resistance: The Potential Of Nanomedicine. Nanomedicine. 2012;7(4):597–615.

Antoszczak M, Huczyński A. Anticancer Activity Of Polyether Ionophore-Salinomycin. Anti-Cancer Agents Med Chem (Formerly Curr Med Chem Agents). 2015;15(5):575–91.

Huang M, Deng Z, Tian J, Liu T. Synthesis And Biological Evaluation Of Salinomycin Triazole Analogues As Anticancer Agents. Eur J Med Chem. 2017 Feb 15;127:900–8.

Huczynski A. Salinomycin - A New Cancer Drug Candidate. Chem Biol Drug Des. 2012 Mar;79(3):235–8.

Wenxuan Z, Wu J, Li B, Xia J, Wu H, Hao J, Wang L, Zhou Q, Wu S. Synthesis And Biological Activity Evaluation Of 20-Epi-Salinomycin And Its 20-O-Acyl Derivatives. RSC Adv. 2016 Apr 26;6.

Naujokat C, Steinhart R. Salinomycin As A Drug For Targeting Human Cancer Stem Cells. J Biomed Biotechnol. 2012;2012:1–17.

Naujokat C, Steinhart R. Salinomycin As A Drug For Targeting Human Cancer Stem Cells. J Biomed Biotechnol. 2012;2012:44–6.

Asuzu DT. Epigenetic Regulation Of Stem Cells In Cancer And Aging. College Of Medicine-Mayo Clinic; 2011.

Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES. Identification Of Selective Inhibitors Of Cancer Stem Cells By High-Throughput Screening. Cell. 2009;138(4):645–59.

Zhou S, Wang F, T Wong E, Fonkem E, Hsieh T-C, M Wu J, Wu E. Salinomycin: A Novel Anti-Cancer Agent With Known Anti-Coccidial Activities. Curr Med Chem. 2013;20(33):4095–101.

Zhi QM, Chen XH, Ji J, Zhang JN, Li JF, Cai Q, Liu BY, Gu QL, Zhu ZG, Yu YY. Salinomycin Can Effectively Kill Aldhhigh Stem-Like Cells On Gastric Cancer. Biomed Pharmacother. 2011;65(7):509–15.

Li Y, Upadhyay S, Bhuiyan M, Sarkar FH. Induction Of Apoptosis In Breast Cancer Cells MDA-MB-231 By Genistein. Oncogene. 1999;18(20):3166–72.

Irmak G, Öztürk MG, Gümüşderelioğlu M. Salinomycin Encapsulated PLGA Nanoparticles Eliminate Osteosarcoma Cells Via Inducing/Inhibiting Multiple Signaling Pathways: Comparison With Free Salinomycin. J Drug Deliv Sci Technol. 2020;58:101834.

Bao B, Ahmad A, Azmi AS, Ali S, Sarkar FH. Overview Of Cancer Stem Cells (Cscs) And Mechanisms Of Their Regulation: Implications For Cancer Therapy. Curr Protoc Pharmacol. 2013 Jun;Chapter 14:Unit 14.25.

Kim J-H, Chae M, Kim WK, Kim Y-J, Kang HS, Kim HS, Yoon S. Salinomycin Sensitizes Cancer Cells To The Effects Of Doxorubicin And Etoposide Treatment By Increasing DNA Damage And Reducing P21 Protein. Br J Pharmacol. 2011 Feb;162(3):773–84.

He M, Fu Y, Yan Y, Xiao Q, Wu H, Yao W, Zhao H, Zhao L, Jiang Q, Yu Z, Jin F, Mi X, Wang E, Cui Z, Fu L, Chen J, Wei M. The Hedgehog Signalling Pathway Mediates Drug Response Of MCF-7 Mammosphere Cells In Breast Cancer Patients. Clin Sci. 2015 Nov 1;129(9):809–22.

An H, Kim JY, Lee N, Cho Y, Oh E, Seo JH. Salinomycin Possesses Anti-Tumor Activity And Inhibits Breast Cancer Stem-Like Cells Via An Apoptosis-Independent Pathway. Biochem Biophys Res Commun. 2015 Oct;466(4):696–703.

Ketola K, Hilvo M, Hyötyläinen T, Vuoristo A, Ruskeepää AL, Orešič M, Kallioniemi O, Iljin K. Salinomycin Inhibits Prostate Cancer Growth And Migration Via Induction Of Oxidative Stress. Br J Cancer. 2012;106(1):99–106.

Huang X, Borgström B, Stegmayr J, Abassi Y, Kruszyk M, Leffler H, Persson L, Albinsson S, Massoumi R, Scheblykin IG, Hegardt C, Oredsson S, Strand D. The Molecular Basis For Inhibition Of Stemlike Cancer Cells By Salinomycin. ACS Cent Sci. 2018 Jun 27;4(6):760–7.

Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome C And Datp-Dependent Formation Of Apaf-1/Caspase-9 Complex Initiates An Apoptotic Protease Cascade. Cell. 1997;91(4):479–89.

Kim J-H, Chae M, Kim WK, Kim Y-J, Kang HS, Kim HS, Yoon S. Salinomycin Sensitizes Cancer Cells To The Effects Of Doxorubicin And Etoposide Treatment By Increasing DNA Damage And Reducing P21 Protein. Br J Pharmacol. 2011 Feb;162(3):773–84.

Fuchs D, Heinold A, Opelz G, Daniel V, Naujokat C. Salinomycin Induces Apoptosis And Overcomes Apoptosis Resistance In Human Cancer Cells. Biochem Biophys Res Commun. 2009 Dec;390(3):743–9.

Kim J-H, Yoo H-I, Kang HS, Ro J, Yoon S. Salinomycin Sensitizes Antimitotic Drugs-Treated Cancer Cells By Increasing Apoptosis Via The Prevention Of G2 Arrest. Biochem Biophys Res Commun. 2012 Feb;418(1):98–103.

Jiang J, Li H, Qaed E, Zhang J, Song Y, Wu R, Bu X, Wang Q, Tang Z. Salinomycin, As An Autophagy Modulator-- A New Avenue To Anticancer: A Review. J Exp Clin Cancer Res. 2018 Dec 13;37(1):26.

Yue W, Hamaï A, Tonelli G, Bauvy C, Nicolas V, Tharinger H, Codogno P, Mehrpour M. Inhibition Of The Autophagic Flux By Salinomycin In Breast Cancer Stem-Like/Progenitor Cells Interferes With Their Maintenance. Autophagy. 2013 May;9(5):714–29.

Xipell E, Gonzalez-Huarriz M, De Irujo JJM, García-Garzón A, Lang FF, Jiang H, Fueyo J, Gomez-Manzano C, Alonso MM. Salinomycin Induced ROS Results In Abortive Autophagy And Leads To Regulated Necrosis In Glioblastoma. Oncotarget. 2016 May 24;7(21):30626–41.

Zhao C-Y, Cheng R, Yang Z, Tian Z-M. Nanotechnology For Cancer Therapy Based On Chemotherapy. Molecules. 2018 Apr 4;23(4).

Liang D-S, Liu J, Peng T-X, Peng H, Guo F, Zhong H-J. Vitamin E-Based Redox-Sensitive Salinomycin Prodrug-Nanosystem With Paclitaxel Loaded For Cancer Targeted And Combined Chemotherapy. Colloids Surf B Biointerfaces. 2018 Dec 1;172:506–16.

Mollazadeh S, Mackiewicz M, Yazdimamaghani M. Recent Advances In The Redox-Responsive Drug Delivery Nanoplatforms: A Chemical Structure And Physical Property Perspective. Mater Sci Eng C. 2021;118:111536.

Zhang S, Li Y, Wu Y, Shi K, Bing L, Hao J. Wnt/Β-Catenin Signaling Pathway Upregulates C-Myc Expression To Promote Cell Proliferation Of P19 Teratocarcinoma Cells. Anat Rec (Hoboken). 2012 Dec;295(12):2104–13.

Li B, Li Q, Mo J, Dai H. Drug-Loaded Polymeric Nanoparticles For Cancer Stem Cell Targeting. Front Pharmacol. 2017 Feb 14;8

Das J, Debbarma A, Lalhlenmawia H. Formulation And In Vitro Evaluation Of Poly-(D, L-Lactide-Co-Glycolide) (Plga) Nanoparticles Of Ellagic Acid And Its Effect On Human Breast Cancer, Mcf-7 Cell Line. Int J Curr Pharm Res. 2021;13(5):56–62.

Tefas LR, Barbălată C, Tefas C, Tomuță I. Salinomycin-Based Drug Delivery Systems: Overcoming The Hurdles In Cancer Therapy. Pharmaceutics. 2021 Jul 22;13(8).

Mao X, Liu J, Gong Z, Zhang H, Lu Y, Zou H, Yu Y, Chen Y, Sun Z, Li W, Li B, Gao J, Zhong Y. Irgd-Conjugated DSPE-PEG2000 Nanomicelles For Targeted Delivery Of Salinomycin For Treatment Of Both Liver Cancer Cells And Cancer Stem Cells. Nanomedicine (Lond). 2015;10(17):2677–95.

Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-Dependent Internalization Of Particles Via The Pathways Of Clathrin- And Caveolae-Mediated Endocytosis. Biochem J. 2004 Jan 1;377(Pt 1):159–69.

Song Y, Cai H, Yin T, Huo M, Ma P, Zhou J, Lai W. Paclitaxel-Loaded Redox-Sensitive Nanoparticles Based On Hyaluronic Acid-Vitamin E Succinate Conjugates For Improved Lung Cancer Treatment. Int J Nanomedicine. 2018;13:1585–600.

Liang DS, Liu J, Peng TX, Peng H, Guo F, Zhong HJ. Vitamin E-Based Redox-Sensitive Salinomycin Prodrug-Nanosystem With Paclitaxel Loaded For Cancer Targeted And Combined Chemotherapy. Colloids Surfaces B Biointerfaces. 2018;172:506–16.

Tefas LR, Barbălată C, Tefas C, Tomuță I. Salinomycin-Based Drug Delivery Systems: Overcoming The Hurdles In Cancer Therapy. Pharmaceutics. 2021 Jul 22;13(8):1120.

Zeng Y-B, Yu Z-C, He Y-N, Zhang T, Du L-B, Dong Y-M, Chen H-W, Zhang Y-Y, Wang W-Q. Salinomycin-Loaded Lipid-Polymer Nanoparticles With Anti-CD20 Aptamers Selectively Suppress Human CD20+ Melanoma Stem Cells. Acta Pharmacol Sin. 2018 Feb;39(2):261–74.

Yao J, Zhang L, Zhou J, Liu H, Zhang Q. Efficient Simultaneous Tumor Targeting Delivery Of All-Trans Retinoid Acid And Paclitaxel Based On Hyaluronic Acid-Based Multifunctional Nanocarrier. Mol Pharm. 2013;10(3):1080–91.

Arabi L, Badiee A, Mosaffa F, Jaafari MR. Targeting CD44 Expressing Cancer Cells With Anti-CD44 Monoclonal Antibody Improves Cellular Uptake And Antitumor Efficacy Of Liposomal Doxorubicin. J Control release. 2015;220:275–86.

Schiffelers RM, Koning GA, Ten Hagen TLM, Fens MHAM, Schraa AJ, Janssen APCA, Kok RJ, Molema G, Storm G. Anti-Tumor Efficacy Of Tumor Vasculature-Targeted Liposomal Doxorubicin. J Control Release. 2003;91(1–2):115–22.

Baldwin PM, Adler J, Davies MC, Melia CD. High Resolution Imaging Of Starch Granule Surfaces By Atomic Force Microscopy. J Cereal Sci. 1998;27(3):255–65.

Kuo Y-C, Chen Y-C. Targeting Delivery Of Etoposide To Inhibit The Growth Of Human Glioblastoma Multiforme Using Lactoferrin-And Folic Acid-Grafted Poly (Lactide-Co-Glycolide) Nanoparticles. Int J Pharm. 2015;479(1):138–49.

Min KH, Park K, Kim Y-S, Bae SM, Lee S, Jo HG, Park R-W, Kim I-S, Jeong SY, Kim K. Hydrophobically Modified Glycol Chitosan Nanoparticles-Encapsulated Camptothecin Enhance The Drug Stability And Tumor Targeting In Cancer Therapy. J Control Release. 2008;127(3):208–18.

Willing BF. Abundance Of Antibiotic Resistance Genes In Feces Following Prophylactic And Therapeutic Intramammary Antibiotic Infusion In Dairy Cattle. Virginia Tech; 2013.

Lautz LS, Nebbia C, Hoeks S, Oldenkamp R, Hendriks AJ, Ragas AMJ, Dorne J. An Open Source Physiologically Based Kinetic Model For The Chicken (Gallus Gallus Domesticus): Calibration And Validation For The Prediction Residues In Tissues And Eggs. Environ Int. 2020;136:105488.

Zhou S, Wang F, Wong ET, Fonkem E, Hsieh T-C, Wu JM, Wu E. Salinomycin: A Novel Anti-Cancer Agent With Known Anti-Coccidial Activities. Curr Med Chem. 2013;20(33):4095–101.

Alexander J, Auðunsson GA, Benford D, Cockburn A, Dogliotti E, Domenico A Di, Férnandez-Cruz ML, Fink-Gremmels J, Galli CL, Grandjean P, Gzyl J, Heinemeyer G, Johansson N, Mutti A, Schlatter J, Leeuwen R Van. Cross-Contamination Of Non-Target Feedingstuffs By Robenidine Authorised For Use As A Feed Additive - Scientific opinion of the Panel on Contaminants in the Food Chain. EFSA J. 2008;6(4):1–38.

Rawal S, Patel MM. Threatening Cancer With Nanoparticle Aided Combination Oncotherapy. J Control Release. 2019;301:76–109.

D’Alessandro S, Corbett Y, Ilboudo DP, Misiano P, Dahiya N, Abay SM, Habluetzel A, Grande R, Gismondo MR, Dechering KJ, Koolen KMJ, Sauerwein RW, Taramelli D, Basilico N, Parapini S. Salinomycin And Other Ionophores As A New Class Of Antimalarial Drugs With Transmission-Blocking Activity. Antimicrob Agents Chemother. 2015 Sep;59(9):5135–44.

Naujokat C, Steinhart R. Salinomycin As A Drug For Targeting Human Cancer Stem Cells. J Biomed Biotechnol. 2018/11/29. 2012 Feb 1 [cited 2021 Dec 6];2012(1):1–17.

Naujokat C. Targeting Human Cancer Stem Cells With Monoclonal Antibodies. J Clin Cell Immunol. 2012;01(S5).

Rollinson J, Taylor FG, Chesney J. Salinomycin Poisoning In Horses. Vet Rec. 1987 Aug 8;121(6):126–8.

Dorne JLCM, Fernández-Cruz ML, Bertelsen U, Renshaw DW, Peltonen K, Anadon A, Feil A, Sanders P, Wester P, Fink-Gremmels J. Risk Assessment Of Coccidostatics During Feed Cross-Contamination: Animal And Human Health Aspects. Toxicol Appl Pharmacol. 2013 Aug 1;270(3):196–208.

Jangamreddy JR, Jain M V, Hallbeck A-L, Roberg K, Lotfi K, Łos MJ. Glucose Starvation-Mediated Inhibition Of Salinomycin Induced Autophagy Amplifies Cancer Cell Specific Cell Death. Oncotarget. 2015 Apr 30;6(12):10134–45.

Jangamreddy Jr, Ghavami S, Grabarek J, Kratz G, Wiechec E, Fredriksson B-A, Rao Pariti Rk, Cieślar-Pobuda A, Panigrahi S, Łos Mj. Salinomycin Induces Activation Of Autophagy, Mitophagy And Affects Mitochondrial Polarity: Differences Between Primary And Cancer Cells. Biochim Biophys Acta. 2013 Sep;1833(9):2057–69.

Schinke C, Fernandez Vallone V, Ivanov A, Peng Y, Körtvelyessy P, Nolte L, Huehnchen P, Beule D, Stachelscheid H, Boehmerle W, Endres M. Modeling Chemotherapy Induced Neurotoxicity With Human Induced Pluripotent Stem Cell (Ipsc) -Derived Sensory Neurons. Neurobiol Dis. 2021 Jul;155:105391.

Naujokat C, Laufer S. Salinomycin, A Candidate Drug For The Salinomycin, A Candidate Drug For The Elimination Of Cancer Stem Cells Elimination Of Cancer Stem Cells. In: Role Of Cancer Stem Cells In Cancer Biology And Therapy. 2013.

Wirawan E, Vanden Berghe T, Lippens S, Agostinis P, Vandenabeele P. Autophagy: For Better Or For Worse. Cell Res. 2012 Jan;22(1):43–61.

Lu Ying Zhong Yanqiang Wang Meiping Zhang He Gao Jie Wen Xi Kai Zhang Siyue Chen Dazhong Geng Wenqian Zhang Ye Ye Gong Zhirong. Salinomycin-Loaded PEG-Ceramide Micelle, Preparation Method And Application Thereof. 2015.

Zeng Zhaowuxiao Renzhongwang Xiaoliwang Junjiezhou Guanglinliu Xingyan. Folic Acid Coupled Polyethylene Glycol Monostearate And Its Preparation Method And Application. 2012.

Published

14-04-2022

How to Cite

RAJ R., G., S., P., PATIL, A. B., JAIN, V., & AJMEER, R. (2022). A REVIEW OF ADVANCED NANOTECHNOLOGIES AND DRUG DELIVERY SYSTEMS OF SALINOMYCIN AND THEIR ROLE IN TRIPLE-NEGATIVE BREAST CANCER. International Journal of Applied Pharmaceutics, 14(4). https://doi.org/10.22159/ijap.2022v14i4.44237

Issue

Section

Review Article(s)